Medical and Pharmaceutical

More women are using marijuana during pregnancy in the U.S. and that might be causing health issues for their babies, two new studies suggest.

The CBD pet market is expected to reach $1.16 billion in the U.S. by 2022, according to the Brightfield Group.

In a study at the Hebrew University of Jerusalem, researchers found rodents treated with a cannabinoid derived from cannabis had significantly better recoveries.

Canada's largest pharmacy chain said Monday it is partnering with B.C.-based TruTrace to deploy a pilot program that uses blockchain to track strains and quality of medical marijuana.

A new study published this week contradicts previous findings that medical marijuana is an effective solution in preventing opioid-related deaths.

Research done by The Associated Press found that in many instances, the broader the state's legalization the more it cuts into medical marijuana programs.

According to patient groups, up to one million people will be eligible to use medical marijuana, a small fraction of the French population of nearly 70 million.

In the study published in The American Journal of Psychiatry, CBD oil was found effective in reducing both cue-induced cravings and anxiety in former heroin users.

Some of Canada's biggest cannabis players are already planting seeds to take advantage of what's expected to be a US$8.5 billion market by 2024, according to Prohibition Partners.

"It is incumbent on our lawmakers to provide physicians with opportunities to discuss alternatives to opioids and to provide patients with choices even if additional research regarding medical marijuana is necessary," Gov. Jared Polis said.

It is first cannabis company from Israel to apply to launch an initial public offering with the Toronto Stock Exchange.

Cannabis industry giant Canopy Growth Corp. (NYSE:CGC)(TSX:WEED) is partnering with drug awareness groups to create digital tools aimed to improve education and help youth, parents and teachers open up and talk about cannabis use.

The passed bill awaits governor approval and will broaden the range of health conditions medical cannabis can treat currently covered by state law.

Advancing study into the substance is “something that wouldn't be possible in the prohibition era,” said Rebecca Haines-Saah of the University of Calgary.

Despite encouraging results, researchers warned parents should wait for more data before they treat their children with autism.

Canopy Growth Corp (NYSE:CGC)(TSX:WEED) expands reach into Europe with a $342.9 million acquisition of medical cannabis company C3, based in Germany C3.

Green Relief Inc. could be an intriguing investment opportunity when it inevitably IPO's.

Zenabis Global Inc (TSX-V:ZENA) announced it is partnering with a pharmaceutical company based out of Germany, Farmako. The two companies are going to be working together on a couple of initiatives, including selling CBD isolate oil in Canada along with selling cannabis to the German medical market.

Columbia Care Inc. (NEO:CCHW) launched on the NEO exchange, becoming the first cannabis company to list on the exchange with a market capitalization of more than a billion dollars.

The Green Organic Dutchman Holdings Ltd (TSX:TGOD) announced last week that its facility in Hamilton, Ontario received a license from Health Canada to sell cannabis oil.

There is a big bill circulating the U.S. government that could have a big impact on the cannabis industry. The Strengthening the Tenth Amendment Through Entrusting States (STATES) Act could lead to significant opportunities in the U.S. It could help open the door to more consolidation of U.S. and Canadian operations and lead to more mergers and acquisitions. Here are five companies to watch for if the bill passes.

Cannabidiol, or CBD, is being touted as a cure-all for everything from anxiety to insomnia but is it good for breastfeeding mothers?

April 20, aka 4/20, is coming up and one way cannabis enthusiasts can celebrate it is with a CBD-infused burger from fast-food chain Carl's Jr. According to the Company, it has enough supply to be able to sell at least 1,000 burgers containing CBD.

The State of Colorado recently updated its sales numbers for cannabis, and they're continuing to slide. With $119 million in sales for February, it was the lowest month that the State had since February of last year when it earned $113 million. It was also the second consecutive month that total cannabis sales were down.

Aphria Inc (TSX:APHA)(NYSE:APHA) and Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) have been very active when it comes to international expansion. And now, the two companies will be able to compete head-on in the German cannabis market.

Marijuana bills across the US made significant progress in various parts of the country. Is more to come?

Lab-made marijuana? Recently, at the University of California in Berkeley, scientists were able to create cannabis compounds without needing to use a plant to harvest them.

Colorado Governor Jared Polis signed a bill that would allow medical marijuana use to be expanded to include autism as a qualifying medical condition.

Back in November of 2018, the State of Michigan officially opened for business when its first medical marijuana dispensary opened. Besides a slow first month where sales hit $7.1 million, the State has seen sales average over $11 million since then.

This past week, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) got a boost in price when analysts at Cowen Inc., an investment bank in the U.S., said that Aurora was its top pick for the sector.

While it might seem odd to some people, many pet owners have been using cannabis to help treat pets that are suffering in pain, relying on the medicinal benefits of cannabidiol (CBD). The danger, however, is when pets are exposed to tetrahydrocannabinol (THC), the high-inducing substance.

The rave reviews that cannabidiol (CBD) has been earning from many patients has not gone unnoticed. Many athletes use CBD, including those that play in the National Hockey League (NHL). And recently, the NHL Alumni Association agreed to work with cannabis giant Canopy Growth Corp. to conduct one or more studies relating to its use.